KRAS and cancer: Functional analysis further revealed that KRAS mutations led to upregulation of WNT, MAPK, and IL-6/JAK/STAT signaling pathways, which are known to facilitate cancer cell proliferation, growth, and invasion, resulting in more aggressive disease and reduced treatment response35–37.